ABsrRACT The bronchodilation produced by increasing intravenous doses of aminophylline, salbutamol, and a combination of aminophylline and salbutamol given in random order was determined in 10 stable asthmatics on three consecutive days. On a fourth day, response to placebo injections was determined. Forced expiratory volume in one second (FEV1) was measured at twominute intervals after each dose until FEV, returned to a new baseline. At no dosage level was there synergy between the two agents in terms of either mean percentage increase in FEV, or the integrated response. The failure to demonstrate synergy has implications both with respect to the clinical use and the underlying mechanism of action of these drugs.
B2 adrenergic stimulants and methyl xanthine derivatives are commonly prescribed together in the management of asthma. B2 adrenergic stimulants increase production of cyclic (3,5) adenosine monophosphate (cyclic AMP) from ATP by stimulation of adenyl cyclase.1 Methyl xanthine derivatives reduce the rate of degradation of cyclic AMP by inhibition of phosphodiesterase.2 Since B2 adrenergic stimulants and methyl xanthine derivatives produce increases in cyclic AMP concentration by different mechanisms, the question arises whether the interaction between these two classes of drug is synergistic3-synergy being defined as an interaction between two agents when given in combination which produces a response greater than the sum of their individual responses.
Synergy has been demonstrated experimentally using guinea pig tracheal muscle, human leucocytes, and human lung fragments4-6 but has not been demonstrated conclusively in vivo. [7] [8] [9] In an attempt to demonstrate synergy we have constructed doseresponse curves to intravenous salbutamol and aminophylline when given separately and in combination.
Methods
Ten well-controlled asthmatics requiring regular inhaled salbutamol and who showed greater than 15 % improvement in forced expiratory volume (FEV1) phylline was administered intravenously at the same time as an inhalation of 0-16-0-18 mg of isoprenaalone (p < 0-05). The linear regression lines for the line.7 The same author was unable to demonstrate three drugs were parallel and showed aminophylline synergy between oral choline theophyllinate and to be lower than salbutamol, which was lower than salmefamol with respect to PEFR. 9 We have used the combination; however, the distance between the standard dose-response curves to salbutamol, intercepts of the salbutamol and the combination aminophylline, placebo, and salbutamol and aminodose-response regression lines was less than that phylline in combination and have shown highly between salbutamol and aminophylline, suggesting significant increases in FEV1 and integrated response therefore that the response to aminophylline and though we have been unable to show synergistic salbutamol when given in combination is less than interaction. This calls into question the mechanism additive.
of action of B adrenergic stimulants and methyl xanthine derivatives. Discussion It is proposed though not proven that B adrenergic stimulants and methyl xanthine derivatives produce We have demonstrated a dose-response relationship bronchodilation by increasing cyclic AMP levels in to small intravenous doses of salbutamol and amino-bronchial smooth muscle. Increased levels of intraphylline, which is statistically highly significant with cellular cyclic AMP stimulate calcium binding to the respect to FEV1 response and "integrated response". cell membrane and the sarcoplasmic reticulum, If synergy between these drugs had occurred then calcium concentration in the myoplasm is thereby one would have expected the dose response curve of reduced and muscle relaxation occurs.10 It is salbutamol combined with aminophylline to be suggested that the adrenaline-induced increase in above and to the left of the salbutamo-curve de-calcium conductance in heart muscle results from picted (fig 1)- 
